| Trade Names: | |
| Synonyms: | |
| Status: | Approved (2013) |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| ATC: | L01XC15 |
| UNII: | O43472U9X8 |
Pharmacology
| Primary Target | |
|---|---|
| CD20 (membrane-spanning 4-domains, subfamily A, member 1) |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Lymphoma, Follicular | 4 | D008224 | ClinicalTrials |
| Neoplasms | 4 | D009369 | ClinicalTrials |
| Lupus Erythematosus, Systemic | 3 | D008180 | ClinicalTrials |
| Kidney Diseases | 3 | D007674 | ClinicalTrials |
| Lupus Nephritis | 3 | D008181 | ClinicalTrials |
| Lymphoma, Non-Hodgkin | 3 | D008228 | ClinicalTrials |
| Lymphoma, Large B-Cell, Diffuse | 3 | D016403 | ClinicalTrials |
| Carcinoma, Non-Small-Cell Lung | 2 | D002289 | ClinicalTrials |
| Lymphoma | 2 | D008223 | ClinicalTrials |
| Lymphoma, Mantle-Cell | 2 | D020522 | ClinicalTrials |
| Waldenstrom Macroglobulinemia | 2 | D008258 | ClinicalTrials |
| Leukemia, Hairy Cell | 2 | D007943 | ClinicalTrials |
| Graft vs Host Disease | 2 | D006086 | ClinicalTrials |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | D054198 | ClinicalTrials |
| Leukemia, Prolymphocytic | 1 | D015463 | ClinicalTrials |
| Leukemia | 1 | D007938 | ClinicalTrials |
| Renal Insufficiency, Chronic | 1 | D051436 | ClinicalTrials |
| Hodgkin Disease | 1 | D006689 | ClinicalTrials |
| Burkitt Lymphoma | 1 | D002051 | ClinicalTrials |
| Mycosis Fungoides | 1 | D009182 | ClinicalTrials |
| Colorectal Neoplasms | 1 | D015179 | ClinicalTrials |
Adverse Reactions
System Organ Classification (SOC)
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 949142-50-1 |
| ChEMBL | CHEMBL1743048 |
| FDA SRS | O43472U9X8 |
| Guide to Pharmacology | 6941 |
CONTENTS